CATCH THE BUZZ – EpiPen should be available for $20, not over $300 says new report
By PharmPro Daily Ill-conceived regulations and bureaucratic red tape emanating from the U.S. Food and Drug Administration (FDA) have inhibited competition and hiked EpiPen…
Read More